{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:27:33Z","timestamp":1790360853391,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,1,28]],"date-time":"2003-01-28T00:00:00Z","timestamp":1043712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt B"],"published-print":{"date-parts":[[2003,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated possible associations between selected polymorphisms in the serotonin receptor genes, <jats:italic>5\u2010HT2A<\/jats:italic> and <jats:italic>5\u2010HT2C<\/jats:italic>, with the presence of co\u2010morbid depressive illness at baseline in a community based cohort of 158 patients with late onset patients with Alzheimer's disease (AD). An association was found between the presence of major depressive illness at baseline and both the 5\u2010HT2A and 5\u2010HT2C polymorphisms. Specifically, homozygous carriers of the 5\u2010HT2A C102 allele were five times more likely to have major depressive illness than heterozygotes. In addition, homozygous or hemizygous carriers of the 5\u2010HT2C Ser allele were 12 times more likely to have major depressive illness than homozygous or hemizygous carriers of the 5\u2010HT2C Cys allele. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.b.10068","type":"journal-article","created":{"date-parts":[[2003,4,17]],"date-time":"2003-04-17T10:02:02Z","timestamp":1050573722000},"page":"40-43","source":"Crossref","is-referenced-by-count":57,"title":["Depression in Alzheimer's disease: The effect of serotonin receptor gene variation"],"prefix":"10.1002","volume":"119B","author":[{"given":"Clive","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,28]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90038-8"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.3.293"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3015"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.11.1472"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12746-4"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199604)11:4<369::AID-GPS429>3.0.CO;2-O"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.9.1507"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.1.45"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.6.777"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1074::AID-GPS696>3.0.CO;2-B"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.1.39"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.3_Part_1.523"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_2_3_15_1","first-page":"407","article-title":"Serotonin in aging, late\u2010life depression, and Alzheimer's disease: The emerging role of functional imaging","volume":"18","author":"Meltzer C","year":"1998","journal-title":"Neuropharmacology"},{"key":"e_1_2_3_16_1","volume-title":"CAMDEX. The Cambridge examination for mental disorders of the elderly","author":"Roth M","year":"1988"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.3.350"},{"key":"e_1_2_3_18_1","unstructured":"ShilohR NuttD WeizmanA.1999.Atlas of Psychiatric Pharmacology. Martin Dunitz Ltd."},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199512000-00041"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/089198879400700306"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.3.338"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62413-0"}],"container-title":["American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.b.10068","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.b.10068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:25:24Z","timestamp":1697037924000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.b.10068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5,15]]}},"alternative-id":["10.1002\/ajmg.b.10068"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.b.10068","archive":["Portico"],"relation":{},"ISSN":["1552-4841","1552-485X"],"issn-type":[{"value":"1552-4841","type":"print"},{"value":"1552-485X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,28]]}}}